Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure

THOUSAND OAKS, Calif., SOUTH SAN FRANCISCO, Calif., and SURESNES, France, Feb. 21, 2019 /PRNewswire/ — Amgen (NASDAQ: AMGN), Cytokinetics, Incorporated (NASDAQ: CYTK) and Servier today announced that METEORIC-HF (Multicenter Exercise Tolerance Evaluation of Omecamtiv Mecarbil Related to Increased Contractility in Heart Failure),…

Zahn Dental Announces New Solutions, Live Educational Events, and Introduction of Zahn Digital Solutions at LMT Lab Day, February 21 – 23, in Chicago, IL

Live Demonstrations Featuring New Equipment Available: vhf’s K5+ Mill, Amann Girrbach’s NextDent 5100 for Ceramill, and EnvisionTEC’s Envision One cDLM 3D PrinterKeynote Speaker Announced: Rella Christensen PhD., RDHLaunch of Zahn Digital Solutions, formerly, Custom Automated Prosthetics (CAP) MELVILLE, N.Y., February…